News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Singh Shawn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Singh Shawn (CEO) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 167 shares
@ $1.5895, valued at
$265.4 |
|
| 01/03/2023 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.0876, valued at
$438 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 3,623 shares
@ $1.6575, valued at
$6k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2020 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.398, valued at
$119.4k
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $1, valued at
$80k
Granted 170,000 options to buy
@ $1, valued at
$170k
|
|
| 01/15/2019 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 21,250 options to buy
@ $1.5, valued at
$31.9k
Exercised 1,125 options to buy
@ $1.5, valued at
$1.7k
Exercised 3,000 options to buy
@ $1.5, valued at
$4.5k
|
|
| 01/14/2019 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $1.7, valued at
$374k
|
|
| 08/31/2018 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 3,000 options to buy
@ $10, valued at
$30k
Granted 3,000 options to buy
@ $1.5, valued at
$4.5k
Disposed/sold 1,125 options to buy
@ $10, valued at
$11.3k
Granted 1,125 options to buy
@ $1.5, valued at
$1.7k
Disposed/sold 50,000 options to buy
@ $10, valued at
$500k
Granted 50,000 options to buy
@ $1.5, valued at
$75k
Disposed/sold 21,250 options to buy
@ $10, valued at
$212.5k
Granted 21,250 options to buy
@ $1.5, valued at
$31.9k
Disposed/sold 5,000 options to buy
@ $10, valued at
$50k
Granted 5,000 options to buy
@ $1.5, valued at
$7.5k
Disposed/sold 200,000 options to buy
@ $3.49, valued at
$698k
|
|
| 02/05/2018 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.16, valued at
$348k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.8, valued at
$380k
|
|
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2016 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,625 shares
@ $0
Disposed/sold 2,500 warrants
@ $10, valued at
$25k
Disposed/sold 5,000 warrants
@ $20, valued at
$100k
|
|
| 11/13/2015 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 4,017 options to buy
@ $10, valued at
$40.2k
Granted 4,017 options to buy
@ $7, valued at
$28.1k
Disposed/sold 1,786 options to buy
@ $10, valued at
$17.9k
Granted 1,786 options to buy
@ $7, valued at
$12.5k
Disposed/sold 72,000 options to buy
@ $12.8, valued at
$921.6k
Granted 72,000 warrants
@ $7, valued at
$504k
Disposed/sold 150,000 options to buy
@ $10, valued at
$1.5M
Granted 150,000 options to buy
@ $7, valued at
$1.1M
Disposed/sold 250,000 options to buy
@ $9.25, valued at
$2.3M
Granted 250,000 options to buy
@ $7, valued at
$1.8M
|
|
| 09/03/2015 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 250,000 warrants
@ $9.25, valued at
$2.3M
|
|
| 01/13/2015 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $10, valued at
$1.5M
|
|
| 12/24/2013 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Disposed/sold 60,000 options to buy
@ $1.13, valued at
$67.8k
Granted 60,000 options to buy
@ $0.5, valued at
$30k
Disposed/sold 22,500 options to buy
@ $1.13, valued at
$25.4k
Granted 22,500 options to buy
@ $0.5, valued at
$11.3k
Disposed/sold 1,000,000 options to buy
@ $1.5, valued at
$1.5M
Granted 1,000,000 options to buy
@ $0.5, valued at
$500k
Disposed/sold 425,000 options to buy
@ $1.5, valued at
$637.5k
Granted 425,000 options to buy
@ $0.5, valued at
$212.5k
Disposed/sold 100,000 options to buy
@ $1.75, valued at
$175k
Granted 100,000 options to buy
@ $0.5, valued at
$50k
|
|
| 10/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2013 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 50,000 shares
@ $0.64, valued at
$32k
Exercised 50,000 warrants
@ $0.64, valued at
$32k
|
|
| 03/05/2013 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Acquired 1,500,000 warrants
@ $0.64, valued at
$960k
|
|
| 12/06/2012 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0.5, valued at
$50k
Granted 50,000 warrants
@ $1.5, valued at
$75k
|
|
| 07/27/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2011 |
3
| Singh Shawn (CEO) has filed a Form 3 on Excaliber Enterprises, Ltd. |
|
|